Latest from Columbia University Medical Center

Melissa K. Accordino, MD, MS, discusses the utility of liquid biopsies in breast cancer.
Katherine D. Crew, MD, MS, discusses recent advances made in HER2-positive breast cancer treatment.
Melissa K. Accordino, MD, MS, discusses the findings of the PEARL trial in hormone receptor-positive, HER2-negative metastatic breast cancer.
Jason D. Wright, MD, discusses the findings of this trial and how practice can shift to decrease the gap between African-American and white patients with endometrial cancer.
Dawn L. Hershman, MD, MS, discusses the design of the phase III TAILORx trial in hormone receptor (HR)–positive, HER2-negative breast cancer.
Katherine D. Crew, MD, MS, discusses the results of the APHINITY trial in HER2-positive breast cancer.
Eileen Connolly, MD, PhD, discusses the possible benefit of postmastectomy radiation for patients with breast cancer.
 
Katherine Crew, MD, MS, discusses treatment for patients with favorable-risk early-stage HER2-positive breast cancer.
Publication Bottom Border
Border Publication
x